Prevention of Deep Vein Thrombosis by Panax Notoginseng Saponins Combined with Low-Molecular-Weight Heparin in Surgical Patients

被引：0
作者：
Chun-mei Wang
Xiang-feng Guo
Li-min Liu
Ying Huang
Liang Meng
Li-po Song
Ying-feng Wu
Ya-chan Ning
Kathleen H. Reilly
Hai-bo Wang
机构：
[1] Capital Medical University,Department of Vascular Surgery, Xuanwu Hospital
[2] Children’s Hospital Capital Institute of Pediatrics,Department of Orthopaedics, Xuanwu Hospital
[3] Capital Medical University,Peking University Clinical Research Institute
[4] Centers for Disease Control and Prevention,undefined
[5] Peking University First Hospital,undefined
来源：
Chinese Journal of Integrative Medicine | 2022年 / 28卷
关键词：
panax notoginseng saponins; deep vein thrombosis; low-molecular-weight heparin; thromboelastography; risk factor;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：771 / 778
页数：7
相关论文
共 50 条
  • [41] Management of primary care patients with suspected deep vein thrombosis use of a therapeutic dose of low-molecular-weight heparin to avoid urgent ultrasonographic evaluation
    Imberti, D
    Ageno, W
    Dentali, F
    Pierfranceschi, MG
    Croci, E
    Garcia, D
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2006, 4 (05) : 1037 - 1041
  • [42] Prophylaxis of thrombosis with low-molecular-weight heparin (LMWH)
    Holzheimer, RG
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2004, 9 (03) : 150 - 170
  • [43] Outpatient therapy with low-molecular-weight heparins:: New perspectives for treatment of deep vein thrombosis
    Büller, HR
    HAEMOSTASIS, 1998, 28 : 91 - 94
  • [44] Combination of Traditional Chinese Medicine and Low-Molecular-Weight Heparin Prevents Deep Vein Thrombosis After Surgery: A Meta-Analysis
    Chen, Chu
    Tang, Qing
    Zhang, Wenjuan
    Yuan, Huijun
    Huai, Ying
    Jiang, Kai
    Wu, Yilun
    Zhao, Heping
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2019, 25
  • [45] Therapy of deep vein thrombosis with low molecular weight heparin, compression bandage and walking exercise
    Partsch, H
    Kechavarz, B
    Mostbeck, A
    Kohn, H
    MEDIZINISCHE WELT, 1997, 48 (02): : 84 - 90
  • [46] Therapy of deep vein thrombosis with low molecular weight heparin, leg compression and immediate ambulation
    Partsch, H
    VASA-JOURNAL OF VASCULAR DISEASES, 2001, 30 (03): : 195 - 204
  • [47] Postoperative versus preoperative initiation of deep-vein thrombosis prophylaxis with a low-molecular-weight heparin (Nadroparin) in elective hip replacement
    Palareti, G
    Borghi, B
    Coccheri, S
    Leali, N
    Golfieri, R
    Montebugnoli, M
    Inghilleri, G
    Ronzio, A
    Barbui, T
    Pogliani, EM
    DiNino, G
    Spotorno, L
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 1996, 2 (01) : 18 - 24
  • [48] Low molecular weight heparins in the prevention of deep-vein thrombosis in general surgery
    Breddin, HK
    SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1999, 25 : 83 - 89
  • [49] Clinical trial of prevention of deep vein thrombosis on implantable infusion devices by a low molecular weight heparin.
    Pucheu, A
    Leduc, B
    SilletBach, I
    Payen, C
    Assaf, W
    Pucheu, M
    ANNALES DE CARDIOLOGIE ET D ANGEIOLOGIE, 1996, 45 (02): : 59 - 63
  • [50] LOW-MOLECULAR-WEIGHT HEPARIN TREATMENT FAILURE IN PREVENTION OF PROSTHETIC MITRAL VALVE THROMBOSIS
    Suran, David
    Kanic, Vojko
    Golob-Gulic, Tatjana
    Naji, Husam Franjo
    Lipovec, Robert
    ZDRAVNISKI VESTNIK-SLOVENIAN MEDICAL JOURNAL, 2009, 78 (02): : 79 - 82
12345